262 related articles for article (PubMed ID: 23820288)
1. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?
Rennyson SL; Shah KB; Tang DG; Kasirajan V; Pedram S; Cahoon W; Malhotra R
ASAIO J; 2013; 59(4):450-1. PubMed ID: 23820288
[TBL] [Abstract][Full Text] [Related]
2. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities.
Molina TL; Krisl JC; Donahue KR; Varnado S
ASAIO J; 2018; 64(4):433-439. PubMed ID: 29406356
[TBL] [Abstract][Full Text] [Related]
4. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.
Loyaga-Rendon RY; Hashim T; Tallaj JA; Acharya D; Holman W; Kirklin J; Pamboukian SV
ASAIO J; 2015; 61(1):107-9. PubMed ID: 25232774
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
[TBL] [Abstract][Full Text] [Related]
6. Experience of the use of octreotide for refractory gastrointestinal bleeding in a patient with Jarvik2000
Nakajima-Doi S; Seguchi O; Shintani Y; Fujita T; Fukushima S; Matsumoto Y; Eura Y; Kokame K; Miyata S; Matsuda S; Mochizuki H; Iwasaki K; Kimura Y; Toda K; Kumai Y; Kuroda K; Watanabe T; Yanase M; Kobayashi J; Fukushima N
J Artif Organs; 2019 Dec; 22(4):334-337. PubMed ID: 31338629
[TBL] [Abstract][Full Text] [Related]
7. Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device.
Juricek C; Imamura T; Nguyen A; Chung B; Rodgers D; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Burkhoff D; Sayer G; Jeevanandam V; Uriel N
J Card Fail; 2018 Apr; 24(4):249-254. PubMed ID: 29427603
[TBL] [Abstract][Full Text] [Related]
8. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience.
Hayes HM; Dembo LG; Larbalestier R; O'Driscoll G
Artif Organs; 2010 Sep; 34(9):703-6. PubMed ID: 20883388
[TBL] [Abstract][Full Text] [Related]
9. Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding.
Kim JH; Brophy DF; Shah KB
Cardiol Clin; 2018 Nov; 36(4):519-529. PubMed ID: 30297069
[TBL] [Abstract][Full Text] [Related]
10. Continuous-flow left ventricular assist devices and gastrointestinal bleeding: potential role of danazol.
Schettle SD; Pruthi RK; Pereira NL
J Heart Lung Transplant; 2014 May; 33(5):549-50. PubMed ID: 24630863
[No Abstract] [Full Text] [Related]
11. Treatment of gastrointestinal bleeding in left ventricular assist devices: A comprehensive review.
Vedachalam S; Balasubramanian G; Haas GJ; Krishna SG
World J Gastroenterol; 2020 May; 26(20):2550-2558. PubMed ID: 32523310
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapeutic Management of Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
Sieg AC; Moretz JD; Horn E; Jennings DL
Pharmacotherapy; 2017 Nov; 37(11):1432-1448. PubMed ID: 28833332
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and Biological Effects of Long-Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices.
Malhotra R; Shah KB; Chawla R; Pedram S; Smallfield MC; Priday AG; DeWilde CT; Brophy DF
ASAIO J; 2017; 63(3):367-370. PubMed ID: 27922890
[TBL] [Abstract][Full Text] [Related]
14. Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide.
Ray R; Kale PP; Ha R; Banerjee D
ASAIO J; 2014; 60(4):482-3. PubMed ID: 24830804
[TBL] [Abstract][Full Text] [Related]
15. Incidence and management of gastrointestinal bleeding with continuous flow assist devices.
Aggarwal A; Pant R; Kumar S; Sharma P; Gallagher C; Tatooles AJ; Pappas PS; Bhat G
Ann Thorac Surg; 2012 May; 93(5):1534-40. PubMed ID: 22541185
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding.
Shah KB; Gunda S; Emani S; Kanwar MK; Uriel N; Colombo PC; Uber PA; Sears ML; Chuang J; Farrar DJ; Brophy DF; Smallfield GB
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141860
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.
Guha A; Eshelbrenner CL; Richards DM; Monsour HP
Methodist Debakey Cardiovasc J; 2015; 11(1):24-7. PubMed ID: 25793026
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device.
Letsou GV; Shah N; Gregoric ID; Myers TJ; Delgado R; Frazier OH
J Heart Lung Transplant; 2005 Jan; 24(1):105-9. PubMed ID: 15653390
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: A comprehensive review.
Del Rio-Pertuz G; Nair N
Artif Organs; 2023 Jan; 47(1):12-23. PubMed ID: 36334280
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile vs. continuous flow in ventricular assist device therapy.
Loor G; Gonzalez-Stawinski G
Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):105-15. PubMed ID: 22910084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
